Skip to main content

Table 1 Patients baseline parameters

From: Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

 

Group 1

Group 2

 

Naive(n = 87)

Experienced(n = 17)

Gender (Male:Female)

30:57

3:14

Age (mean ± SD)

42.9 ± 10.6

47.29 ± 8.92

ALTs (IU/ml ± SD)

74.8 ± 60.1

94.1 ± 78.8

BMI (± SD)

23.88 ± 6.6

24.64 ± 5.2

Cholesterol (± SD)

181.42 ± 38.2

188.07 ± 22.9

Triglycerides (± SD)

177.16 ± 53.22

170.15 ± 50.03

Base line Quant (range)

1 × 103-5.8 × 106

1 × 103-2 × 106

LDL (normal/high)

58/4

13/0

HDL(normal/high)

58/4

13/0

Inflammation

  

A1

38 (.43)

9 (.53)

A2

5 (.057)

1 (.058)

A3

15 (.17)

5 (.294)

Not done

29 (.33)

2 (.11)

Fibrosis

  

F0

45(.52)

10(.59)

F1

13(.15)

3(.17)

F2

5(.005)

1(.005)

F3

1(.001)

0

Not done

23(.26)

3(.17)

  1. A1, A2, A3 are mild, moderate and marked inflammation respectively
  2. F0, F1, F2, F3 are no, mild, moderate and marked fibrosis respectively